Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Debt / NOTE 4.000%11/1
-
Number of holders
-
11
-
Total 13F principal, excl. options
-
21.4M
-
Principal change
-
+265K
-
Total reported value, excl. options
-
$40.7M
-
Value change
-
+$259K
-
Number of buys
-
2
-
Number of sells
-
-1
-
Price
-
$0.99
Significant Holders of ESPERION THERAPEUTICS INC NE - NOTE 4.000%11/1 as of Q2 2025
11 filings reported holding 29664WAB1 - ESPERION THERAPEUTICS INC NE - NOTE 4.000%11/1 as of Q2 2025.
ESPERION THERAPEUTICS INC NE - NOTE 4.000%11/1 has 11 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of $21.4M of principal
.
Largest 10 bondholders include Pentwater Capital Management LP ($10.9M of principal), PenderFund Capital Management Ltd. ($3M of principal), DeepCurrents Investment Group LLC ($2.4M of principal), Jefferies Financial Group Inc. ($1.75M of principal), OAKTREE CAPITAL MANAGEMENT LP ($1.46M of principal), Russell Investments Group, Ltd. ($1.11M of principal), ZAZOVE ASSOCIATES LLC ($375K of principal), ZAZOVE ASSOCIATES LLC ($375K of principal), DCF Advisers, LLC ($100K of principal), and Context Capital Management, LLC ($12.4K of principal).
This table shows the top 11 institutional bondholders of the company debt. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.